Business Description
Translate Bio Inc
NAICS : 325412
SIC : 2833
ISIN : US89374L1044
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.53 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.12 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.11 | |||||
Beneish M-Score | 3.05 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 54.8 | |||||
Future 3-5Y Total Revenue Growth Rate | -14.75 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 53.41 | |||||
12-1 Month Momentum % | 168.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.8 | |||||
Quick Ratio | 8.8 | |||||
Cash Ratio | 8.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 18.52 | |||||
Net Margin % | 17.97 | |||||
FCF Margin % | 131.53 | |||||
ROE % | 11.26 | |||||
ROA % | 5 | |||||
ROIC % | 16.58 | |||||
ROC (Joel Greenblatt) % | 55.08 | |||||
ROCE % | 5.83 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 73.83 | |||||
PE Ratio without NRI | 73.83 | |||||
PS Ratio | 12.87 | |||||
PB Ratio | 6.82 | |||||
Price-to-Tangible-Book | 8.9 | |||||
Price-to-Free-Cash-Flow | 9.68 | |||||
Price-to-Operating-Cash-Flow | 9.51 | |||||
EV-to-EBIT | 53.13 | |||||
EV-to-EBITDA | 42.75 | |||||
EV-to-Revenue | 9.84 | |||||
EV-to-FCF | 7.48 | |||||
Price-to-Graham-Number | 5.4 | |||||
Price-to-Net-Current-Asset-Value | 12.54 | |||||
Price-to-Net-Cash | 16.1 | |||||
Earnings Yield (Greenblatt) % | 1.88 | |||||
FCF Yield % | 10.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Translate Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 225.086 | ||
EPS (TTM) ($) | 0.506 | ||
Beta | 0 | ||
Volatility % | 113.1 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.403571 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 168.61 | ||
52-Week Range ($) | 11.91 - 37.985 | ||
Shares Outstanding (Mil) | 75.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Translate Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Translate Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Translate Bio Inc Frequently Asked Questions
What is Translate Bio Inc(TBIO)'s stock price today?
When is next earnings date of Translate Bio Inc(TBIO)?
Does Translate Bio Inc(TBIO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |